Patents by Inventor Iranzu González De La Tajada

Iranzu González De La Tajada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASES
    Publication number: 20120308517
    Abstract: The present invention relates to the use of compositions comprising a type III interferon and oncostatin M and to the use of said compositions for the treatment and prevention of infectious and neoplastic diseases.
    Type: Application
    Filed: February 7, 2011
    Publication date: December 6, 2012
    Applicants: DIGNA BIOTECH, S.L., PROYECTO DE BIOMEDICINA CIMA, S.L.
    Inventors: Rafael Aldabe Arregui, Iranzu Gonzalez De La Tajada, Maria Esther Larrea Leoz, Jesus Maria Prieto Valtuena
  • ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS
    Publication number: 20110195047
    Abstract: The invention relates to the use of oncostatin M (OSM), an OSM receptor (OSMR) agonist, or a combination of OSM or a OSMR agonist with an interferon type I; in the manufacture of a medicament for enhancing the immunostimulatory activity of epithelial cells in a human.
    Type: Application
    Filed: October 6, 2009
    Publication date: August 11, 2011
    Applicant: PROYECTO DE BIOMEDICINA CIMA, S.L.
    Inventors: Rafael Aldabe Arregui, Iranzu González De La Tajada, Maria Esther Larrea Leoz, Jesús Maria Prieto Valtueña, Pablo Sarobe Ugarriza
  • Non-human animal sarcoma model
    Publication number: 20090217390
    Abstract: The invention disclosed in this application relates to a method designed to obtain a non-human animal model for sarcoma characterised in that it comprises: transfecting cells derived from a multipotent mesenchymal cell line with an expression vector that contains a polynucleotide which encodes a fusion protein selected from EWS-FLI1, EWS-ERG, EWS-ETV1, EWS-ETV4, EWS-FEV, EWS-ATF1, EWS-WT1, EWS-NR4A3 and EWS-DDIT3; and injecting said transfected cells in the animal that is the model subject. Similarly, this invention relates to the animal model itself and its applications, as well as the transfected cell line and the applications thereof.
    Type: Application
    Filed: April 29, 2005
    Publication date: August 27, 2009
    Inventors: Fernando Lecanda Cordero, Iranzu Gonzalez De La Tajada